Loading company…
Xiushi develops and manufactures peptide and protein products using biosynthesis.
Xiushi Biopharmaceutical provides biosynthesis solutions for peptide drug partners and researches, manufactures, and sells APIs, preparations, enzymes, functional peptides, and protein products. Its biosynthesis approach has been applied to short and complex cyclic peptides. Founded in 2020, the company is based in Nantong, China. In August 2025, it raised Series A funding from Arshine Group, Cui Capital, Daoxing Investment, Huatai Zijin Investment, and Jinding Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in